TrialHepatology (Baltimore, Md.)2014

Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection.

Jens M Werner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.